High Blood Eosinophil Count at Stable State is Not Associated with Airway Microbiota Distinct Profile in COPD
DOI: https://doi.org/10.2147/copd.s453526
2024-03-18
International Journal of COPD
Abstract:Jeanne-Marie Perotin, 1, 2 Anaëlle Muggeo, 3 Quentin Lecomte-Thenot, 3 Audrey Brisebarre, 1 Sandra Dury, 2 Claire Launois, 1, 2 Julien Ancel, 1, 2 Valérian Dormoy, 1 Thomas Guillard, 3 Gaëtan Deslee 1, 2 1 Université de Reims Champagne-Ardenne, INSERM UMR-S 1250, P3Cell, Reims, France; 2 CHU de Reims, Service des Maladies Respiratoires, Reims, France; 3 Université de Reims Champagne-Ardenne, INSERM UMR-S 1250, P3Cell, CHU de Reims, Laboratoire de bactériologie-Virologie-Hygiène hospitalière-Parasitologie-Mycologie, Reims, France Correspondence: Jeanne-Marie Perotin, Service des Maladies Respiratoires, CHU Maison Blanche, Inserm UMR-S 1250, 45 Rue Cognacq-Jay, Reims cedex, 51092, France, Email Purpose: The heterogeneity of clinical features in COPD at stable state has been associated with airway microbiota. Blood eosinophil count (BEC) represents a biomarker for a pejorative evolution of COPD, including exacerbations and accelerated FEV 1 decline. We aimed to analyse the associations between BEC and airway microbiota in COPD at stable state. Patients and Methods: Adult COPD patients at stable state (RINNOPARI cohort) were included and characterised for clinical, functional, biological and morphological features. BEC at inclusion defined 2 groups of patients with low BEC < 300/mm 3 and high BEC ≥ 300/mm 3 . Sputa were collected and an extended microbiological culture was performed for the identification of viable airway microbiota. Results: Fifty-nine subjects were included. When compared with the low BEC (n=40, 67.8%), the high BEC group (n=19, 32.2%) had more frequent exacerbations (p< 0.001) and more pronounced cough and sputum (p< 0.05). The global composition, the number of bacteria per sample and the α-diversity of the microbiota did not differ between groups, as well as the predominant phyla (Firmicutes), or the gender repartition. Conclusion: In our study, high BEC in COPD at stable state was associated with a clinical phenotype including frequent exacerbation, but no distinct profile of viable airway microbiota compared with low BEC. Keywords: COPD, eosinophil, sputum, microbiota Chronic obstructive pulmonary disease (COPD) is characterized by chronic respiratory symptoms including dyspnea, cough, sputum production, and exacerbations, due to abnormalities of the airways and/or alveoli that cause persistent, often progressive airflow limitation. 1 COPD is a heterogeneous disease regarding clinical features, with high morbidity and mortality. The pathogenesis of COPD is still not completely elucidated, including structural and inflammatory changes. 1 Blood eosinophil count (BEC) has been recently identified as a biomarker of interest in stable COPD. Greater BEC levels have been associated with greater FEV 1 decline in the absence of inhaled corticosteroid (ICS) treatment, and with the risk of exacerbation. 1,2 It is currently recommended to use BEC, not as a standalone biomarker but together with exacerbation history, to identify patients with the greatest likelihood of ICS treatment benefit. 1,3 Airway microbiota at stable state might participate in the heterogeneity of COPD clinical presentation. Previous studies performed in a stable state identified associations between the sputum microbiome and COPD phenotypes. 4–6 Associations with COPD inflammatory phenotypes including eosinophils have been recently investigated, suggesting that different profiles of bacteria phyla might be associated with different profiles of inflammation: low sputum eosinophil count in the presence of potential pathogenic microorganism (PPM), 7,8 more diverse respiratory microbiome in subjects with BEC ≥2%. 9 However, the relationships between BEC and airway microbiota and its clinical implications remain to be determined. The most frequently used techniques for airway microbiota analyses (PCR amplification, sequencing of the bacterial 16S ribosomal RNA gene) do not involve bacterial culture. We previously described an extended conventional culture-based approach, allowing the identification of bacteria restricted to viable strains. 6,10 In this study, we applied this culture technique and compared viable airway microbiota in COPD patients at a stable state with high and low BEC. Patients with mild to severe COPD were included prospectively in the RINNOPARI cohort (Recherche et INNOvation en PAthologie Respiratoire Inflammatoire; University Hospital of Reims, France; NCT02924818) as described previously 6 The regional ethics committee ap -Abstract Truncated-
respiratory system